It is intended to evaluate the effect of a marketed cream (Alantel®) based on natural products at high concentrations for the preventive and curative treatment (early stages) of radiation-induced dermatitis in cancer patients. For this, an experimental, prospective, controlled clinical trial, with two parallel arms, double blind, multicentre, will be carried out in which doctors will recruit 78 patients aged 14 years or over in Primary Care consultations. more, diagnosed with cancer, and having received radiotherapeutic cancer treatment, being randomly assigned to the experimental group (cosmetic cream) or the control group (emollient and moisturizing cream). The main variable will be the incidence rate of mild post-translational dermatitis and its improvement or cure once it has been established.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
78
Application on the affected skin of the cream to be tested
Application on the affected skin of the emollient and moisturizing substance
University of Cordoba
Córdoba, Spain
Incidence of radiation-induced dermatitis
Time frame: three weeks
Analog visual scale
Analog visual scale from 0 to 10 points to assess the symptomatology perceived by the patient (pain, stinging, ..)
Time frame: three weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.